...
【24h】

Neutrophils - A key component of ischemia-reperfusion injury

机译:中性粒细胞——一个关键的组成部分缺血再灌注损伤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ischemia-reperfusion injury (IRI) is a common occurrence following myocardial infarction, transplantation, stroke, and trauma that can lead to multiple organ failure, which remains the foremost cause of death in critically ill patients. Current therapeutic strategies for IRI are mainly palliative, and there is an urgent requirement for a therapeutic that could prevent or reverse tissue damage caused by IRI. Neutrophils are the primary responders following ischemia and reperfusion and represent important components in the protracted inflammatory response and severity associated with IRI. Experimental studies demonstrate neutrophil infiltration at the site of ischemia and show that inducing neutropenia can protect organs from IRI. In this review, we highlight the mechanisms involved in neutrophil recruitment, activation, and adherence and how this contributes to disease severity in IRI. Inhibiting neutrophil mobilization, tissue recruitment, and ultimately neutrophil-associated activation of local and systemic inflammatory responses may have therapeutic potential in the amelioration of local and remote tissue damage following IRI.
机译:缺血再灌注损伤(IRI)是一种常见的发生心肌梗死后,会导致移植、中风和创伤多器官功能衰竭,这仍然是最重要的死因在病危病人。主要是缓和,迫切要求治疗可以预防或反向IRI造成的组织损伤。中性粒细胞是主要的反应缺血再灌注和代表重要组件在长期炎症响应与IRI和严重程度相关。实验研究证明中性粒细胞渗透在缺血和显示诱导中性粒细胞减少可以保护器官IRI。参与中性粒细胞招募,激活,和依从性,这导致疾病IRI的严重性。动员、组织招聘,最终当地和neutrophil-associated激活系统性炎症反应治疗潜在的改进本地和远程IRI后组织损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号